Please login to the form below
real-world data
This page shows the latest real-world data news and features for those working in and with pharma, biotech and healthcare.
Boehringer Ingelheim to boost antibody discovery with partner Twist
June the company signed a deal with AI developer Lifebit on tech that can rapidly scan scientific publications and real-world health data from around the world to identify potential new
Latest news
-
Boehringer Ingelheim to boost antibody discovery with partner Twist
June the company signed a deal with AI developer Lifebit on tech that can rapidly scan scientific publications and real-world health data from around the world to identify potential new
-
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Real-world data shows similar safety profile for Vaxzevria and mRNA-based jabs. ... AstraZeneca has revealed new real-world data in a bid to continue establishing the ‘favourable’ benefit-risk profile of its COVID-19 vaccine Vaxzevria.
-
One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
New real-world data from Canada shows vaccine efficacy was lower against milder symptomatic disease with one dose. ... New real-world data has demonstrated that one dose of AstraZeneca’s COVID-19 vaccine is ‘highly effective’ at reducing severe
-
Pfizer, BioNTech eye US approval for COVID-19 booster dose
Pfizer’s chief medical officer Mikael Dolsten reportedly told The Associated Press that preliminary data from the company’s vaccine booster study indicates that antibodies increase five- to ten-fold following ... New real-world data, collected over
-
Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
Data suggests vaccine is 64% effective at preventing infection caused by Delta variant after two doses. ... New real-world data, collected over the last month, now suggests the jab is 64% effective at preventing infection after both doses, following the
Boehringer Ingelheim to boost antibody discovery with partner Twist
AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
Pfizer, BioNTech eye US approval for COVID-19 booster dose
Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
More from news
Approximately 13 fully matching, plus 129 partially matching documents found.
Latest Intelligence
-
Communicating for change – creating effective medical communications
We have amazing resources and tools available to us: real-world data, patient- reported outcomes, libraries of clinical outcomes, and dramatically increased access to healthcare professionals (HCPs) and patients via smart
-
Empowering patients empowers results
These devices are linked through secure networks via the cloud that allow clinicians to view and analyse the data in real time. ... A significant incentive for decentralised trials is the collection of real-world data and real-world evidence, which
-
New thinking, bold action: building a better future for people living with severe diseases
Beyond the COVID-19 pandemic, we announced the launch of several new digital initiatives including a new collaboration with doc.ai, a leading AI platform specialising in collecting real-world data ... The goal is to build an AI model using patient data
-
Mapping the patient journey: eight ways to improve support programmes
In some areas, such as gene therapies and high-cost cancer treatments, accelerated approval and early access schemes are conditional on capturing real-world outcomes data – and patient support tools provide ... They’re a great way of bringing the
-
Medicinal data – what’s next for IDMP?
Hindsight is a wonderful thing, and we are not there yet, but COVID-19 has helped to crystallise the potential of data standards, such as IDMP, in real-world use cases, ... EU-wide agreement on data exchange between regulators and industry would be ideal,
Communicating for change – creating effective medical communications
Empowering patients empowers results
New thinking, bold action: building a better future for people living with severe diseases
Mapping the patient journey: eight ways to improve support programmes
Medicinal data – what’s next for IDMP?
More from intelligence
Approximately 7 fully matching, plus 74 partially matching documents found.
Latest appointments
-
Astellas appoints new senior VP
pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.
-
Dr Ameet Nathwani moves from Novartis to Sanofi
Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products
Astellas appoints new senior VP
Dr Ameet Nathwani moves from Novartis to Sanofi
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Cegedim Health Data
Driving standards across the industry, our expertise in data management provides precise, ethical, actionable and fully anonymised patient data. ... We think outside the box to support our customers to deliver the application of data, intelligence and
-
Cegedim Health Data UK
We are your trusted partner for Real World Data (RWD), Real World Evidence (RWE), Advanced Analytics and Health Data Services. ... Cegedim Health Data UK.
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
autumn. In 2020, the onset of the COVID-19 pandemic brought the world to a halt. ... Both of these technologies have benefited greatly from the vaccine race, with a large quantity of clinical trial data and real-world evidence generated to support their
-
Three things to consider when using social listening research for patient recruitment
A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. ... Getting the right kind of data from social listening begins with asking the
-
Wilmington Healthcare appoints new Solutions Director
Bringing together all disciplines, from analytical, development, commercial and marketing to underpin Wilmington Healthcare’s ambitious growth plans, Kirsty will ensure customers continue to receive trusted insight and real-world data ... In this time,
Cegedim Health Data
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
Three things to consider when using social listening research for patient recruitment
Wilmington Healthcare appoints new Solutions Director
More from PMHub
Approximately 1 fully matching, plus 55 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- bluebird bio gears up for split
- EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Accelerating Drug Development Timelines with Big Data Analytics
- A Lucid Group Thirsty Thursday Special: Beautiful Rejects
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US orders 1.4 million more doses of Regeneron antibody cocktail
- Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- Ovid wins Communiqué Small Consultancy of the Year award at Communiqué 2021
- Lucid Group celebrates a double win at Communiqué 2021
- Future of MHRA uncertain amid Brexit-fuelled shake up
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
